Authority EmpireRituximab – A Cancer Drug – May Treat Sufferers Of Chronic Fatigue SyndromeAuthority EmpireNorway researchers report that they can treat Chronic Fatigue Syndrome with the cancer treatment drug Rituximab (Rituxan), which is a biologi…
Chronic Fatigue Syndrome — A Treatable Autoimmune DiseaseHuffington Post (blog)They decided to treat 30 people with CFS, mainly young (average age 37.3 for those treated and 31.5 years for placebo) and female (80 percent) with rituximab, a potent anti…
Driven by the Launch and Uptake of Human Genome Sciences/GlaxoSmithKline's …MarketWatch (press release)The continued uptake of the premium-priced B-cell modulator rituximab will help to drive SLE market growth. Rituximab will achieve sales of nea…
Treatment for Chronic Fatigue Syndrome developed from cancer drug RituximabActive QuoteCancer drug Rituximab has been shown to successfully treat the symptoms of chronic fatigue syndrome (CFS), supporting the theory that CFS is an autoimmune disease. A…
Daily MailChronic Fatigue Syndrome: Study Supports Autoimmune Disease TheoryABC NewsTwo injections of the cancer drug Rituximab, which suppresses the immune system, relieved chronic fatigue symptoms in 10 of 15 patients several months later, according …
DrumBeat With Silence Charumbira: Dhewa's music legacy lives onThe Zimbabwe StandardWhen Dhewa died, he had started receiving Rituximab, a cancer drug invented in India. It is one of the latest cancer drugs and is said to be the best. However, when…
Daily MailMeet the first child in Britain to benefit from a pioneering kidney transplant …Daily MailDuring the procedure, the patient is given an injection of a drug called Rituximab a month before the transplant to suppress the immune system, stoppi…
Daily MailNabeel Nanuck kidney transplant: 1st child in Britain that didn't require a …Daily MailDuring the procedure, the patient is given an injection of a drug called Rituximab a month before the transplant to suppress the immune system, stopp…
Rituximab Clinical Trial Q&A, Developed by the ME AssociationProHealthby ME Association Following is an informative Q&A on the rituximab ME/CFS trial, the drug, and future research issues posted Oct 20 by Tony Britton & Dr. Charles Shepherd…
Ocrelizumab Benefits in MS Maintained to 96 WeeksMedscapeRituximab, an anti-CD20 monoclonal antibody that selectively reduces CD20-positive B-cells, showed "proof of concept" efficacy in MS in phase 1 and 2 investigations, they say. Ocrelizum…